4-(Chlorthio)-benzoesaure | 476423-85-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-(Chlorthio)-benzoesaure
• 英文别名: 4-chlorosulfanylbenzoic acid
• CAS: 476423-85-5
• 化学式: C₇H₅ClO₂S
• 分子量: 188.63
• InChiKey: VYLGCYVHKBHYGQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  62.6
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• Substituted-aryl compounds for treatment of disease
  申请人：——

  公开号：US20030236279A1

  公开（公告）日：2003-12-25

  The invention provides compounds of Formula I: 1 These compounds may be in the form of pharmaceutical salts or compositions, racemic mixtures, or pure enantiomers thereof. The compounds of Formula I are useful in pharmaceuticals to treat diseases or conditions in which &agr;7 is known to be involved.

  该发明提供了I式化合物：1这些化合物可以是药用盐或组合物的形式，可以是消旋混合物，也可以是其纯对映体。I式化合物在药物中用于治疗已知与α7有关的疾病或症状。
• Quinuclidine-substituted aryl compounds for treatment of disease
  申请人：——

  公开号：US20020040035A1

  公开（公告）日：2002-04-04

  The invention provides compounds of Formula I: 1 These compounds may be in the form of pharmaceutical salts or compositions, and racemic mixtures or pure enantiomers thereof. The compounds of Formula I are useful in pharmaceuticals in which &agr;7 is known to be involved.

  该发明提供了Formula I中的化合物：这些化合物可以是药用盐或组合物的形式，也可以是它们的外消旋混合物或纯对映体。Formula I中的化合物在已知涉及α7的药物中是有用的。
• PROCESS FOR PRODUCING POLYMER TERMINATED WITH OPTIONALLY PROTECTED FUNCTIONAL GROUP
  申请人：KURARAY Co. LTD.

  公开号：EP0704460A1

  公开（公告）日：1996-04-03

  A process for producing polymers having terminal functional group which may be protected, comprises polymerizing a radical-polymerizable monomer with a polymerization initiator comprising at least one member selected from the group (A) consisting of thio-S-carboxylic acids represented by the following general formula (1) and dithiocarboxylic acids represented by the following general formula (2) and at least one member selected from the group (B) consisting of polysulfides represented by the following general formula (3), polysulfides represented by the following general formula (4) and sulfoxides: wherein R¹ represents a hydrocarbon group which may have a substituent including functional group; wherein R² represents a hydrocarbon group which may have a substituent including functional group; wherein R³ and R⁴ each represents a hydrocarbon group which may have a substituent including functional group and n is an integer of 2 or more; and         R⁵- (S)m- R⁶     (4) wherein R⁵ and R⁶ each represents a hydrocarbon group having a functional group and m is an integer of 2 or more. This process can produce polymers with which functional groups have been introduced into one end or both ends thereof, irrespective of the rate of polymerization or the degree of polymerization of the polymer that forms.

  一种生产具有可被保护的末端官能团的聚合物的工艺，包括用聚合引发剂聚合可自由基聚合的单体，聚合引发剂包括至少一种选自以下通式(1)代表的硫代-S-羧酸和以下通式(2)代表的二硫代羧酸组成的基团(A)，以及至少一种选自以下通式(3)代表的多硫化物、以下通式(4)代表的多硫化物和氧化硫组成的基团(B)： 其中 R¹ 代表烃基，该烃基可能具有包括官能团在内的取代基； 其中 R² 代表可具有包括官能团在内的取代基的烃基； 其中 R³ 和 R⁴ 各自代表一个可具有包括官能团在内的取代基的烃基，且 n 为 2 或 2 以上的整数；以及 R⁵- (S)m- R⁶ (4) 其中，R⁵ 和 R⁶ 分别代表具有官能团的烃基，m 为 2 或 2 以上的整数。无论聚合速度或形成的聚合物的聚合度如何，该工艺都能生产出在一端或两端引入官能团的聚合物。
• QUINUCLIDINE-SUBSTITUEDARYL MOIETIES FOR TREATMENT OF DISEASE ( NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS )
  申请人：PHARMACIA & UPJOHN COMPANY

  公开号：EP1381603A2

  公开（公告）日：2004-01-21
• SUBSTITUTED ARYL COMPOUNDS FOR TREATMENT OF DISEASE
  申请人：PHARMACIA & UPJOHN COMPANY

  公开号：EP1480977A2

  公开（公告）日：2004-12-01